1 - 1 / 1 1 |
1. Therapy-type related long-term outcomes in mucopolysaccaridosis type II (Hunter syndrome) Mojca Žerjav-Tanšek, Jana Kodrič, Simona Klemenčič, Jaap Jan Boelens, Peter M. van Hasselt, Ana Drole Torkar, Maja Dorič, Alenka Koren, Simona Avčin, Tadej Battelino, Urh Grošelj, 2021, review article Keywords: MPS, mucopolysaccharidosis type II, Hunter syndrome, hematopoietic stem cell transplantation, HSCT, enzyme replacement therapy |